Forty Seven. Medical animation.
A medical animation for Forty Seven introducing its research into 5F9 monotherapy. Gilead acquired the biotech company in 2020.
- Project
- Client work · Forty Seven
- Format
- Medical animation · Biotechnology
- Length
- 2 minutes 41 seconds
5F9 monotherapy
The subject of this film is research at the scale of a cell. The animation gives the audience a visual reference for the explanation: individual cells can be picked out by shape and colour, and labels direct attention to the part under discussion. The film reflects Forty Seven’s research at the time of production.
Starting with the science
For a biotech team commissioning an animation, an early decision is what the viewer already knows. A scientific audience may recognise a term immediately. Someone seeing it for the first time may need a visual introduction before the explanation moves on. That decision shapes the script, the labels and how long each image stays on screen.
Other formats in the portfolio
The two examples below come from separate projects. Health AI was made for a trade show, where viewers can join an explanation halfway through. Opu Coin is an explainer built around a single subject. Together they show how the setting and the audience can change the format of a brief.
